Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum Aspirin and NT-proBNP
NCT05889468Phase 4Completed
- Sponsor
- Duke University
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aspirin in preeclampsia and eclampsia (2 arms), sponsored by Duke University. Primary endpoint: N-terminal pro-brain natriuretic peptide Levels. Started Jul 2023; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaeclampsia
Beyond the preview
Go deeper on NCT05889468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05889468.